Stockreport
Global Oncology Drugs Market Size To Worth USD 564.50 Billion By 2033 | CAGR Of 11.50% [Yahoo! Finance]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
USD 564.50 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Pfizer Inc, Amgen Inc., Novartis AG, GSK plc, Eli Lilly and Company, AstraZeneca PLC, AbbVie Inc., Ono Pharmaceutical Company, Johnson and Johnson, Astellas Pharma Inc, Bayer Healthcare, Hoffmann-La Roche Ltd., and Others Key Vendors. New York, United States , June 18, 2024 (GLOBE NEWSWIRE) -- The Global Oncology Drugs Market Size is to Grow from USD 190.10 Billion in 2023 to USD 564.50 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 11.50% during the projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4487 Oncology drugs are medications used to treat cancer, a category of disorders caused by the uncontrolled development and division of abnormal cells, they include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Major pharmaceutical companies focus on innovation to improve treatments,
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Global Immunomodulator Market Projected to Nearly Double, Reaching $477.55 Billion by 2034 - Evolution of Immunomodulatory Treatments for Cancer Creating Lucrative Opportunities for Oncology Applications [Yahoo! Finance][Yahoo! Finance]
- Global Pharmaceutical Marketing Industry Research Report 2024-2030: Market Size Projections for Conference Marketing, PPC Advertising, Print Advertising, Social Media Campaigns, TV Commercials, and More [Yahoo! Finance][Yahoo! Finance]
- Why Amgen (AMGN) Outpaced the Stock Market Today [Yahoo! Finance][Yahoo! Finance]
- PDE4 Inhibitor Market to Exhibit Substantial Growth Rate During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance][Yahoo! Finance]
- BMS expands Krazati's FDA label to include colorectal cancer [Yahoo! Finance][Yahoo! Finance]
- More
AMGN
SEC Filings
SEC Filings
- 6/21/24 - Form 11-K
- 6/21/24 - Form 11-K
- 6/12/24 - Form S-8
- AMGN's page on the SEC website
- More